Last reviewed · How we verify
Dexamethasone Passive Patch
Glucocorticoid receptor agonist
Glucocorticoid receptor agonist Used for Neoplasm, Neurological disorders.
At a glance
| Generic name | Dexamethasone Passive Patch |
|---|---|
| Sponsor | Travanti Pharma Inc. |
| Drug class | Glucocorticoid |
| Target | Glucocorticoid receptor |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 2 |
Mechanism of action
Dexamethasone acts as a synthetic glucocorticoid receptor agonist, which leads to anti-inflammatory and immunosuppressive effects.
Approved indications
- Neoplasm
- Neurological disorders
Common side effects
- Cushing's syndrome
- Insomnia
- Headache
Key clinical trials
- Dexamethasone Iontophoretic Patch for the Treatment of Pain Associated With Lateral Epicondylitis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |